Article metrics

Original research
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer

 

Online download statistics by month:

Online download statistics by month: December 2023 to October 2024

AbstractFullPdf
Dec 2023798801158
Jan 2024453455234
Feb 202422222267
Mar 2024295300135
Apr 2024246246100
May 202427527457
Jun 202416416466
Jul 202445946363
Aug 202411011045
Sep 202415915970
Oct 202423023098
Total341134241093